CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Master's Degrees
Doctorate Programs
Training stays
Training contracts and grants
Collaborate with us
How to collaborate
Diseases
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2022-23
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Endoplasmic Reticulum Stress Response in Neurodegenerative Diseases
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Liquid Biopsy and Carcinogenesis
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Non-Coding RNA and Cancer Genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Regenerative Medicine
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA Biology and Therapy
Solid Tumor
Therapeutic Innovation
Therapeutic Non-Coding RNA, Microproteins and Integrated Stress in Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Discovery of how a type of myelodysplastic syndrome functions
Researchers at Cima and the Clínica Universidad de Navarra reveal new clues about the mechanisms of a rare disease that affects bone marrow cells
September 11, 2024
Un nuevo tratamiento combinado de radioterapia e inmunoterapia mejora la supervivencia en modelos preclínicos de tumores cerebrales pediátricos
Investigadores del Cima y de la Clínica Universidad de Navarra demuestran que el bloqueo una molécula inmunitaria durante la radioterapia es una terapia más eficaz para los gliomas difusos de línea media
September 6, 2024
Identifican dos compuestos que orientan nuevos tratamientos para un tipo de leucemia
Investigadores del Cima y de la Clínica Universidad de Navarra demuestran que dos potentes inhibidores, CM-444 y CM-1758, tienen capacidad para promover la diferenciación mieloide en todos los subtipos de leucemia mieloide aguda
August 7, 2024
Cima and Clínica Universidad de Navarra participate in SPACETIME, a consortium project funded with 12 million euros by the European Union
15 partners from 7 European countries will carry out fundamental research on lung cancer for five years.
August 1, 2024
Dr. Gloria González-Aseguinolaza, Rosalind Franklin Society Special Science Award
The director of the Gene Therapy for Rare Diseases Program at the Cima University of Navarra receives this recognition for her contribution to gene therapy research.
July 30, 2024
Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma
Scientists from Cima and the Clínica Universidad de Navarra describe the immune system in patients with multiple myeloma, and observe that immunological changes influence the efficacy of vaccines such as that against COVID-19
July 23, 2024
